CA Stock MarketDetailed Quotes

Aptose Biosciences Inc (APS)

Watchlist
  • 2.190
  • 0.0000.00%
15min DelayMarket Closed Jun 12 16:00 ET
5.59MMarket Cap-0.15P/E (TTM)

Aptose Biosciences Inc (APS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-5.84%24.72M
239.64%7.43M
-29.46%4.91M
-5.77%6.92M
-44.05%5.46M
-49.85%26.26M
-81.97%2.19M
-40.37%6.97M
-49.18%7.35M
-30.76%9.76M
Selling and administrative expenses
19.98%13.36M
49.62%3.95M
19.34%2.7M
23.64%3.62M
-6.50%3.09M
-28.36%11.14M
-12.09%2.64M
-33.85%2.26M
-24.13%2.93M
-37.17%3.31M
-General and administrative expense
19.98%13.36M
49.62%3.95M
19.34%2.7M
23.64%3.62M
-6.50%3.09M
-28.36%11.14M
-12.09%2.64M
-33.85%2.26M
-24.13%2.93M
-37.17%3.31M
Research and development costs
-24.91%11.34M
860.18%3.47M
-53.11%2.21M
-25.27%3.3M
-63.32%2.36M
-58.92%15.1M
-105.01%-457K
-43.05%4.7M
-58.30%4.41M
-26.85%6.45M
Depreciation amortization depletion
15.79%22K
0.00%4K
200.00%12K
-20.00%4K
-50.00%3K
-61.22%19K
-50.00%4K
-60.00%4K
-58.33%5K
-66.67%6K
-Depreciation and amortization
15.79%22K
0.00%4K
200.00%12K
-20.00%4K
-50.00%3K
-61.22%19K
-50.00%4K
-60.00%4K
-58.33%5K
-66.67%6K
Operating profit
5.84%-24.72M
-239.64%-7.43M
29.46%-4.91M
5.77%-6.92M
44.05%-5.46M
49.85%-26.26M
81.97%-2.19M
40.37%-6.97M
49.18%-7.35M
30.76%-9.76M
Net non-operating interest income (expenses)
-592.00%-738K
-336.84%-332K
-1,866.67%-212K
-218.28%-110K
-169.42%-84K
-86.97%150K
-144.44%-76K
-94.83%12K
-71.47%93K
-71.33%121K
Non-operating interest income
-70.59%105K
----
----
----
----
-68.98%357K
-23.39%131K
-94.83%12K
-71.47%93K
-71.33%121K
Non-operating interest expense
307.25%843K
----
----
--110K
--84K
--207K
----
----
----
----
Total other finance cost
----
----
1,866.67%212K
218.28%110K
----
----
----
---12K
---93K
----
Other net income (expenses)
-101.03%-7K
-99.85%1K
2K
-12K
300.00%2K
33,950.00%677K
67,700.00%678K
50.00%-1K
Gain on sale of security
-101.03%-7K
-99.85%1K
--2K
---12K
300.00%2K
33,950.00%677K
67,700.00%678K
----
----
50.00%-1K
Income before tax
-0.15%-25.47M
-389.53%-7.76M
26.32%-5.12M
2.88%-7.04M
42.50%-5.54M
50.34%-25.43M
86.74%-1.59M
39.26%-6.95M
48.67%-7.25M
29.51%-9.64M
Income tax
Earnings from equity interest net of tax
Net income
-0.15%-25.47M
-389.53%-7.76M
26.32%-5.12M
2.88%-7.04M
42.50%-5.54M
50.34%-25.43M
86.74%-1.59M
39.26%-6.95M
48.67%-7.25M
29.51%-9.64M
Net income continuous operations
-0.15%-25.47M
-389.53%-7.76M
26.32%-5.12M
2.88%-7.04M
42.50%-5.54M
50.34%-25.43M
86.74%-1.59M
39.26%-6.95M
48.67%-7.25M
29.51%-9.64M
Noncontrolling interests
Net income attributable to the company
-0.15%-25.47M
-389.53%-7.76M
26.32%-5.12M
2.88%-7.04M
42.50%-5.54M
50.34%-25.43M
86.74%-1.59M
39.26%-6.95M
48.67%-7.25M
29.51%-9.64M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-0.15%-25.47M
-389.53%-7.76M
26.32%-5.12M
2.88%-7.04M
42.50%-5.54M
50.34%-25.43M
86.74%-1.59M
39.26%-6.95M
48.67%-7.25M
29.51%-9.64M
Diluted earnings per share
71.39%-10.41
-288.55%-3.07
82.26%-2.01
78.75%-2.76
88.15%-2.61
84.00%-36.38
98.17%-0.7901
78.54%-11.33
80.93%-12.99
66.94%-22.02
Basic earnings per share
71.39%-10.41
-288.55%-3.07
82.26%-2.01
78.75%-2.76
88.15%-2.61
84.00%-36.38
98.17%-0.7901
78.54%-11.33
80.93%-12.99
66.94%-22.02
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -5.84%24.72M239.64%7.43M-29.46%4.91M-5.77%6.92M-44.05%5.46M-49.85%26.26M-81.97%2.19M-40.37%6.97M-49.18%7.35M-30.76%9.76M
Selling and administrative expenses 19.98%13.36M49.62%3.95M19.34%2.7M23.64%3.62M-6.50%3.09M-28.36%11.14M-12.09%2.64M-33.85%2.26M-24.13%2.93M-37.17%3.31M
-General and administrative expense 19.98%13.36M49.62%3.95M19.34%2.7M23.64%3.62M-6.50%3.09M-28.36%11.14M-12.09%2.64M-33.85%2.26M-24.13%2.93M-37.17%3.31M
Research and development costs -24.91%11.34M860.18%3.47M-53.11%2.21M-25.27%3.3M-63.32%2.36M-58.92%15.1M-105.01%-457K-43.05%4.7M-58.30%4.41M-26.85%6.45M
Depreciation amortization depletion 15.79%22K0.00%4K200.00%12K-20.00%4K-50.00%3K-61.22%19K-50.00%4K-60.00%4K-58.33%5K-66.67%6K
-Depreciation and amortization 15.79%22K0.00%4K200.00%12K-20.00%4K-50.00%3K-61.22%19K-50.00%4K-60.00%4K-58.33%5K-66.67%6K
Operating profit 5.84%-24.72M-239.64%-7.43M29.46%-4.91M5.77%-6.92M44.05%-5.46M49.85%-26.26M81.97%-2.19M40.37%-6.97M49.18%-7.35M30.76%-9.76M
Net non-operating interest income (expenses) -592.00%-738K-336.84%-332K-1,866.67%-212K-218.28%-110K-169.42%-84K-86.97%150K-144.44%-76K-94.83%12K-71.47%93K-71.33%121K
Non-operating interest income -70.59%105K-----------------68.98%357K-23.39%131K-94.83%12K-71.47%93K-71.33%121K
Non-operating interest expense 307.25%843K----------110K--84K--207K----------------
Total other finance cost --------1,866.67%212K218.28%110K---------------12K---93K----
Other net income (expenses) -101.03%-7K-99.85%1K2K-12K300.00%2K33,950.00%677K67,700.00%678K50.00%-1K
Gain on sale of security -101.03%-7K-99.85%1K--2K---12K300.00%2K33,950.00%677K67,700.00%678K--------50.00%-1K
Income before tax -0.15%-25.47M-389.53%-7.76M26.32%-5.12M2.88%-7.04M42.50%-5.54M50.34%-25.43M86.74%-1.59M39.26%-6.95M48.67%-7.25M29.51%-9.64M
Income tax
Earnings from equity interest net of tax
Net income -0.15%-25.47M-389.53%-7.76M26.32%-5.12M2.88%-7.04M42.50%-5.54M50.34%-25.43M86.74%-1.59M39.26%-6.95M48.67%-7.25M29.51%-9.64M
Net income continuous operations -0.15%-25.47M-389.53%-7.76M26.32%-5.12M2.88%-7.04M42.50%-5.54M50.34%-25.43M86.74%-1.59M39.26%-6.95M48.67%-7.25M29.51%-9.64M
Noncontrolling interests
Net income attributable to the company -0.15%-25.47M-389.53%-7.76M26.32%-5.12M2.88%-7.04M42.50%-5.54M50.34%-25.43M86.74%-1.59M39.26%-6.95M48.67%-7.25M29.51%-9.64M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -0.15%-25.47M-389.53%-7.76M26.32%-5.12M2.88%-7.04M42.50%-5.54M50.34%-25.43M86.74%-1.59M39.26%-6.95M48.67%-7.25M29.51%-9.64M
Diluted earnings per share 71.39%-10.41-288.55%-3.0782.26%-2.0178.75%-2.7688.15%-2.6184.00%-36.3898.17%-0.790178.54%-11.3380.93%-12.9966.94%-22.02
Basic earnings per share 71.39%-10.41-288.55%-3.0782.26%-2.0178.75%-2.7688.15%-2.6184.00%-36.3898.17%-0.790178.54%-11.3380.93%-12.9966.94%-22.02
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
The U.S.-Iran peace talks have entered a critical window! On the 14th, Iranian sources indicated that Pakistan will host a video conference Show More